Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South Asia, Africa and the Middle East. Presenting below are its Q1 FY26 earnings results.
Q1 FY26 Earnings Results
-
Revenue: ₹386 crores, up 23% YoY (Q1 FY25: ₹313.4–315.8 crores) and up 18% QoQ (Q4 FY25: ₹333.5 crores).
-
Profit After Tax (PAT): ₹45 crores, up 18.4% YoY (Q1 FY25: ₹38.1 crores), up 23.8% QoQ (Q4 FY25: ₹36.5 crores).
-
Earnings Per Share (EPS): ₹8.7, up 17.4% YoY and 22.5% QoQ (Q1 FY25: ₹7.4; Q4 FY25: ₹7.1).
-
EBITDA: ₹89.8 crores, up 14% YoY (Q1 FY25: ₹78.8 crores); group EBITDA margins at 23.1% (organic margin 24.7%, up 0.4pp QoQ); margin contracted slightly due to low-margin acquisition integration.
-
Profit Before Tax (PBT): ₹61.2 crores, up 19.9% YoY and 21.2% QoQ.
-
Total Expenses: ₹332.4 crores, up 25.5% YoY and 17.4% QoQ.
-
Segmental Growth: Specialty diagnostics revenue up 32% YoY, B2C revenue up 19% YoY, B2B up 29% YoY.
-
Volumes: Patient and test volumes up 11% and 12% YoY, respectively; revenue per patient up 11% YoY, revenue per test up 10% YoY.
-
Recent Acquisitions: Core Diagnostics, DAPIC Dehradun, and Scientific Pathology Agra integrated successfully, expanding specialty business and regional footprint.
-
**TruHealth preventive portfolio and innovation-led upselling continue to drive premium segment growth.
Management Commentary & Strategic Highlights
-
CEO Ameera Shah cited strong organic momentum aided by richer test mix, scientific engagement, and innovation, driving record growth in both B2C and specialty segments.
-
Acquisition synergies are yielding in lab consolidation, procurement, and margin improvement; management targets group margin expansion in coming quarters.
-
Expansion into Tier 2/3 markets, digital engagement, and radiology pilots are fueling new patient volume growth and customer engagement.
-
Management expects stable margins, disciplined M&A, and ongoing growth in specialty diagnostics as drivers for H2 and FY26.
Q4 FY25 Earnings Results
-
Revenue: ₹345 crores.
-
PAT: ₹29 crores.
-
EPS: ₹5.63.
-
EBITDA Margin: 23%.
To view the company’s previous earnings and latest concall transcripts, click here to visit the Alphastreet India news channel.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,